Live feed08:30:00·897dPRReleasevia QuantisnowAditxt, Inc.'s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.'s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 MillionByQuantisnow·Wall Street's wire, on your screen.ADTX· Aditxt Inc.Health Care
